Risk Factors for Gemcitabine-Induced Vascular Pain in Patients With Pancreatic Cancer.

Shigeru IshidaYoko MakiharaHiroyuki WatanabeTakafumi NakashimaKenichiro NagataKimitaka SuetsuguToshikazu TsujiKojiro HataMunehiko IkedaMio IkebeHaruna MinamiHitomi WatanabeKohei NakataMasafumi NakamuraNobuaki EgashiraIchiro Ieiri

Published in: The Annals of pharmacotherapy (2020)

High gemcitabine dosages and lack of hot pack use were predictive factors for gemcitabine-induced vascular pain in patients with pancreatic cancer. Patients receiving gemcitabine treatment should apply a hot pack to the injection site. Scrupulous clinical attention is required for patients presenting with these risk factors to improve pain management.

Keyphrases

pain management
chronic pain
locally advanced
risk factors
high glucose
diabetic rats
drug induced
radiation therapy
spinal cord
postoperative pain